LADENBURG THALMANN FINANCIAL SERVICES INC. - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 41 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2019$2,000
-33.3%
4810.0%0.00%
Q3 2019$3,0000.0%4810.0%0.00%
Q2 2019$3,0000.0%4810.0%0.00%
Q1 2019$3,0000.0%4810.0%0.00%
Q4 2018$3,000
-40.0%
4810.0%0.00%
Q3 2018$5,000
+25.0%
4810.0%0.00%
Q2 2018$4,0000.0%4810.0%0.00%
Q1 2018$4,0000.0%4810.0%0.00%
Q4 2017$4,000
+33.3%
4810.0%0.00%
Q3 2017$3,000
-75.0%
481
-75.0%
0.00%
Q2 2017$12,000
+20.0%
1,9220.0%0.00%
Q1 2017$10,000
-23.1%
1,9220.0%0.00%
Q4 2016$13,000
-7.1%
1,9220.0%0.00%
Q3 2016$14,000
-12.5%
1,9220.0%0.00%
Q2 2016$16,000
+100.0%
1,922
+33.3%
0.00%
Q1 2016$8,0000.0%1,4420.0%0.00%
Q4 2015$8,000
+33.3%
1,4420.0%0.00%
Q3 2015$6,000
-14.3%
1,4420.0%0.00%
Q2 2015$7,000
+16.7%
1,4420.0%0.00%
Q1 2015$6,0001,4420.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders